Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-005875
Filing Date
2023-04-13
Accepted
2023-04-13 16:31:01
Documents
104
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K acgn-20221231x10k.htm   iXBRL 10-K 3863690
2 EX-4.22 acgn-20221231xex4d22.htm EX-4.22 83104
3 EX-4.23 acgn-20221231xex4d23.htm EX-4.23 37304
4 EX-10.24 acgn-20221231xex10d24.htm EX-10.24 47868
5 EX-10.25 acgn-20221231xex10d25.htm EX-10.25 44444
6 EX-10.26 acgn-20221231xex10d26.htm EX-10.26 42636
7 EX-10.30 acgn-20221231xex10d30.htm EX-10.30 25964
8 EX-10.39 acgn-20221231xex10d39.htm EX-10.39 29270
9 EX-23.1 acgn-20221231xex23d1.htm EX-23.1 31140
10 EX-31.1 acgn-20221231xex31d1.htm EX-31.1 23897
11 EX-31.2 acgn-20221231xex31d2.htm EX-31.2 24590
12 EX-32.1 acgn-20221231xex32d1.htm EX-32.1 7874
13 EX-32.2 acgn-20221231xex32d2.htm EX-32.2 8137
14 GRAPHIC acgn-20221231x10k001.jpg GRAPHIC 6431
  Complete submission text file 0001558370-23-005875.txt   13102996

Data Files

Seq Description Document Type Size
15 EX-101.SCH acgn-20221231.xsd EX-101.SCH 94292
16 EX-101.CAL acgn-20221231_cal.xml EX-101.CAL 80160
17 EX-101.DEF acgn-20221231_def.xml EX-101.DEF 394077
18 EX-101.LAB acgn-20221231_lab.xml EX-101.LAB 682707
19 EX-101.PRE acgn-20221231_pre.xml EX-101.PRE 617327
98 EXTRACTED XBRL INSTANCE DOCUMENT acgn-20221231x10k_htm.xml XML 1847942
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31918 | Film No.: 23818725
SIC: 2836 Biological Products, (No Diagnostic Substances)